Integrative chemogenomic analysis identifies small molecules that partially rescue ΔF508‐CFTR for cystic fibrosis

Rare diseases affect 10% of the first‐world population, yet over 95% lack even a single pharmaceutical treatment. In the present age of information, we need ways to leverage our vast data and knowledge to streamline therapeutic development and lessen this gap. Here, we develop and implement an innov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:CPT Pharmacometrics Syst Pharmacol
Autors principals: Hodos, Rachel A., Strub, Matthew D., Ramachandran, Shyam, Meleshkevitch, Ella A., Boudko, Dmitri Y., Bridges, Robert J., Dudley, Joel T., McCray, Paul B.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129714/
https://ncbi.nlm.nih.gov/pubmed/33934548
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12626
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars